Central nervous system (CNS) aspergillosis carries a uniformly poor prognosis in bone marrow transplant recipients. Amphotericin B can be bound to lipid carriers leading to improvement of its therapeutic index. We describe the successful medical management of CNS aspergillosis in an allogeneic bone marrow transplant patient with administration of Amphotericin B Lipid Complex.
|Number of pages||2|
|Journal||Bone Marrow Transplantation|
|State||Published - Jul 2 1997|
- Amphotericin B
- Marrow transplantation